THE Native Antigen Company has launched a new range of tests for the Zika virus, which represents a major step forward in the fight against the disease.
The Oxford-based company’s new non-crossreactive Zika virus tests are more sensitive and accurate than current tests, but can also distinguish between Zika and similar viruses such as Dengue.
The new product range comes as the Oxford-based company reports a third consecutive year of growth
Dr Nick Roesen, COO of The Native Antigen Company, said: “The Zika virus poses a significant global risk and there is currently no vaccine or specific treatment.”
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here